These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29169331)

  • 61. Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke.
    Thrift AG; Kim J; Douzmanian V; Gall SL; Arabshahi S; Loh M; Evans RG
    Stroke; 2014 Feb; 45(2):539-44. PubMed ID: 24335222
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hemorrhage after ischemic stroke - relation to age and previous hemorrhage in a nationwide cohort of 58,868 patients.
    Åsberg S; Henriksson KM; Farahmand B; Terént A
    Int J Stroke; 2013 Feb; 8(2):80-6. PubMed ID: 22168375
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of antiplatelet drugs in the stroke unit of a Hong Kong hospital.
    Luk HH; Pang J; Li LS; Ng M
    Pharm World Sci; 2005 Jun; 27(3):258-62. PubMed ID: 16096898
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
    Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Shifting Perceptions of Risk and Reward: Use of Anticoagulation in Patients With Acute Brain Ischemia and Atrial Fibrillation: Nine-Year Data From a National Acute Stroke Registry (National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Tsabari R; Orion D; Merzlyak O; Haratz S; Peretz S; Bornstein NM; Ifergane G; Einhorn M; Schwammenthal E; Geva D; Tanne D;
    Stroke; 2017 Apr; 48(4):1092-1094. PubMed ID: 28258255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiplatelet therapy in diabetic ischemic stroke patients: associated factors and outcomes.
    Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
    Int J Clin Pharmacol Ther; 2011 Oct; 49(10):605-13. PubMed ID: 21961485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
    Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Secondary prevention in a large stroke population: a study of patients' purchase of recommended drugs.
    Wettermark B; Persson A; von Euler M
    Stroke; 2008 Oct; 39(10):2880-5. PubMed ID: 18688006
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimal combination secondary prevention drug treatment and stroke outcomes.
    Park JH; Ovbiagele B
    Neurology; 2015 Jan; 84(1):50-6. PubMed ID: 25411440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications.
    Béjot Y; Zeller M; Lorgis L; Troisgros O; Aboa-Eboulé C; Osseby GV; Giroud M; Cottin Y
    J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):348-53. PubMed ID: 23152636
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the European and Japanese guidelines for the management of ischemic stroke.
    Kern R; Nagayama M; Toyoda K; Steiner T; Hennerici MG; Shinohara Y
    Cerebrovasc Dis; 2013; 35(5):402-18. PubMed ID: 23712178
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.
    Khedri M; Szummer K; Carrero JJ; Jernberg T; Evans M; Jacobson SH; Spaak J
    Eur J Prev Cardiol; 2017 May; 24(7):724-734. PubMed ID: 28195517
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).
    Coull BM; Williams LS; Goldstein LB; Meschia JF; Heitzman D; Chaturvedi S; Johnston KC; Starkman S; Morgenstern LB; Wilterdink JL; Levine SR; Saver JL; ;
    Neurology; 2002 Jul; 59(1):13-22. PubMed ID: 12105302
    [No Abstract]   [Full Text] [Related]  

  • 77. Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study.
    Rosafio F; Lelli N; Mimmi S; Vandelli L; Bigliardi G; Dell'Acqua ML; Picchetto L; Pentore R; Ferraro D; Trenti T; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1864-1873. PubMed ID: 28576652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack.
    Yeh PS; Lin HJ; Bai CH; Hsieh FI; Ke DS; Li YH;
    Am J Cardiol; 2010 May; 105(10):1490-4. PubMed ID: 20451701
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
    Chen CY; Lee KT; Lee CT; Lai WT; Huang YB
    Int J Stroke; 2014 Jul; 9(5):580-90. PubMed ID: 24597578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.